Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer
Clinical trial NCT06322147 · UNKNOWN
Trial details
- NCT number
- NCT06322147
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-01
- Primary completion
- 2024-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.